|Table of Contents|

Influence of 18F-FDG PET/CT dual time imaging on the diagnostic accuracy of hepatocellular carcinoma in elderly patients

Journal Of Modern Oncology[ISSN:1672-4992/CN:61-1415/R]

Issue:
2018 06
Page:
914-917
Research Field:
Publishing date:

Info

Title:
Influence of 18F-FDG PET/CT dual time imaging on the diagnostic accuracy of hepatocellular carcinoma in elderly patients
Author(s):
Chi Qi1; Zhang Lingling2; Mo Minghua3
1.Medical Imaging Intervention Department；2.Neurology;3.The Medical Imaging Department，General Hospital of Fushun Mining Bureau of Liaoning Province,Liaoning Fushun 113000,China.
Keywords:
18F-FDG PET／CT; hepatocellular carcinoma; early phase and delayed phase
PACS:
R735.7
DOI:
10.3969/j.issn.1672-4992.2018.06.024
Abstract:
Objective:To investigate the different manifestations of 18F-FDG,PET/CT in the diagnosis of hepatocellular carcinoma(HCC) in elderly patients,and to determine whether it can improve the accuracy of HCC diagnosis.Methods:Two hospitals were selected respectively in 120 cases,with pathological confirmation.included liver cancer group and benign lesion group.After 18F-FDG PET/CT for liver surgery was underwent,the maximum standard uptake value(SUVmax) and retention index of the lesions in the early and delayed phases were calculated,and the ratio of the lesion SUVmax to the liver basal SUVmax(T/N) was calculated.The change of lesion in HCC group and benign lesion group was analyzed.Results:The difference between the early stage and the delayed phase of SUVmax in the HCC group was statistically significant.There was no significant difference in the benign lesion group between the early stage and the delayed phase SUVmax.The ratio of T/N in HCC group was significantly different between the early stage and the delayed phase.There was no significant difference in the ratio of T/N between the early stage and the delayed phase in the benign lesion group.The difference of retention index between the two groups was not statistically significant.Conclusion:18F-FDG,PET/CT dual phase imaging can improve the accuracy of the diagnosis of hepatocellular carcinoma.

References:

[1] Wang Xuemei,Hai Long,Su Xiulan,et al.18F-FDG PET/CT imaging evaluation of H22 model of HCC and the effect of ursolic acid inhibition on liver cancer［J］.Journal of Chinese Clinician,2012,4(05):1149-1152.
[2] Jian Zhang,Changjing Zuo.The clinical utility of FDG PET/CT among solid organ transplant recipients suspected of malignancy or infection［J］.Gastroenterol,2017,21(10):2988-2996.
[3] Brian S Pugmire,Alexander R Guimaraes,Ciprian Catana.The Role of 18F-FDG PET/CT Integrated Imaging in Distinguishing Malignant from Benign Pleural Effusion［J］.Radiol,2016,8(3):322-330.
[4] Ankur Pruthi,Promila Pankaj,Ritu Verma.Evaluation of radiation exposure to staff and environment dose from 18F-FDG in PET/CT and cyclotron center using thermoluminescent dosimetry［J］.Gastrointest Oncol,2016,7(3):449-461.
[5]Jian Zhang,Changjing Zuo,Ningyang Jia.Cross-modality PET/CT and contrast-enhanced CT imaging for pancreatic cancer［J］.Gastroenterol，2015,21(10):2988-2996.
[6] Bundhit Tantiwongkosi,Fang Yu,Anand Kanard,et al.Sodium 18F-Fluoride PET/CT of bone,joint and other disorders［J］.Radiol,2016,6(5):177-191.
[7] Wang Shuying,Li Qun.The value of 18F-FDG PET/CT in diagnosis of hepatic metastatic carcinoma and its primary and extrahepatic metastases［J］.Journal of Chinese Clinical Physicians,2011,5(20):5904-5908.
[8] John Freebody,Eva A Wegner,Monica A Rossleigh.Adenocarcinoma with BAC features presented as the nonsolid nodule is prone to be false-negative on 18F-FDG PET/CT［J］.Radiol,2016,6(10):741-755.
[9] Musaddiq J Awan,Farzan Siddiqui,David Schwartz.The pearl of FDG PET/CT in preoperative assessment of patients with potentially operable non-small-cell lung cancer and its clinical impact［J］.Radiol,2016,7(11):382-393.
[10] Wang Quanshi,Wang Xinlu,LiHua,et al.The clinical application value of positron emission computed tomography -CT examination before and after liver transplantation of liver cancer patients［J］.Journal of Radiology of China,2005,39(11):52-56.
[11] Subramanyam Padma,Palaniswamy Shanmuga.Staging recurrent ovarian cancer with 18FDG PET/CT［J］.Med Paediatr Oncol,2016,37(3):131-140.
[12] Ankur Pruthi,Promila Pankaj,Ritu Verma,et al.Posttreatment FDG PET/CT in predicting survival of patients with ovarian carcinoma［J］.Gastrointest Oncol,2016,7(3):449-461.
[13] Jujuan Wang,Dongjiao Wang,Qingbo Zhang,et al.The clinical utility of FDG PET/CT among solid organ transplant recipients suspected of malignancy or infection［J］.Cancer Res Clin Oncol,2016,142:859-871.
[14] Guo Mingjiang, Chen Longhua, Jin Wudong.Comparison of PET-CT and MRI with spiral CT in primary liver cancer detection［J］.Journal of Chinese Cancer Prevention and Control,2008,15(11):852-854.
[15] Niraj Naswa,Punit Sharma,Aftab Hasan Nazar.18F-FDG silicon photomultiplier PET/CT:A pilot study comparing semi-quantitative measurements with standard PET/CT［J］.Nucl Med,2016,29(2):94-96.

Memo

Memo:
-
Last Update: 2018-01-29